Literature DB >> 924515

Further purification and chemical characterization of the lymphocyte-inhibiting-factor extracted from thymus (LIFT).

N Kiger, I Florentin, G Lorans, G Mathe.   

Abstract

A thymic extract which was previously demonstrated to contain a lymphocyte-inhibiting-factor (LIFT) based on its immunosuppressive activity in vivo and its antiproliferative properties on lymphocytes in vitro, has been purified using ultrafiltration procedures. Most of the activity measured by the ability to inhibit DNA synthesis in short term cultures of mouse thymocytes, was recovered in the 10,000-50,000 m. wt fraction (I fraction). In contrast, similar extracts from non-lymphoid organs were always ineffective in decreasing DNA synthesis in thymocytes. The I fraction was also inhibitory of DNA synthesis in mouse spleen cells stimulated by PHA whatever the time at which the fraction was added after the mitogen stimulation. This fraction, as well as the crude thymic extract, was ineffective in decreasing DNA synthesis in non-lymphoid target cells. The I fraction was further purified by Sephadex G50 filtration and DEAE Sephadex chromatography. The active molecule seemed to be a heat resistant basic peptide probably bound to a ribonucleotide moiety.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 924515      PMCID: PMC1445394     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  18 in total

1.  Isolation of an immunosuppressive peptide fraction from human plasma.

Authors:  J C Occhino; A H Glasgow; S R Cooperband; J A Mannick; K Schmid
Journal:  J Immunol       Date:  1973-03       Impact factor: 5.422

2.  Some effects of a partially purified lymphocyte-inhibiting factor from calf thymus.

Authors:  N Kiger; I Florentin; G Mathé
Journal:  Transplantation       Date:  1972-10       Impact factor: 4.939

3.  Regulation of T lymphocyte function by immunoregulatory alphaglobulin (IRA).

Authors:  J O Menzoian; A H Glasgow; R D Nimberg; S R Cooperband; K Schmid; I Saporoschetz; J A Mannick
Journal:  J Immunol       Date:  1974-07       Impact factor: 5.422

4.  The effects of human serum fractions on phytohemagglutinin- and concanavalin A-stimulated human lymphocyte cultures.

Authors:  P S Chase
Journal:  Cell Immunol       Date:  1972-12       Impact factor: 4.868

5.  Alpha-2-globulins in renal graft rejection. Effects of in vitro lymphocyte function.

Authors:  R R Riggio; G H Schwartz; F G Bull; K H Stenzel; A L Rubin
Journal:  Transplantation       Date:  1969-11       Impact factor: 4.939

6.  T lymphocyte specificity of a lymphocyte-inhibiting factor (chalone) extracted from the thymus.

Authors:  I Florentin; N Kiger; G Mathé
Journal:  Eur J Immunol       Date:  1973-10       Impact factor: 5.532

7.  A lymphocyte-inhibiting factor (chalone?) extracted from thymus: immunosuppressive effects.

Authors:  N Kiger; I Florentin; G Mathé
Journal:  Natl Cancer Inst Monogr       Date:  1973-07

8.  Inhibition of in vitro lymphocyte blastogenesis by inhibitor produced by cultured human lymphoblasts.

Authors:  E M Hersh; K B McCredie; E J Freireich
Journal:  Clin Exp Immunol       Date:  1974-07       Impact factor: 4.330

9.  Immunosuppressive alpha globulin from bovine thymus and serum: mode of action upon afferent and efferent arcs of the mouse immune response.

Authors:  S M Phillips; C B Carpenter; P Lane
Journal:  Ann N Y Acad Sci       Date:  1975-02-28       Impact factor: 5.691

10.  Inhibition of graft-versus-host reaction by preincubation of the graft with a thymic extract (lymphocyte chalone).

Authors:  N Kiger; I Florentin; G Mathé
Journal:  Transplantation       Date:  1973-11       Impact factor: 4.939

View more
  6 in total

1.  Tissue-specific inhibitor of lymphocyte proliferation extracted and purified from calf spleen. Biological and chemical properties.

Authors:  E Heidemann; N Podgornik; K Wilms
Journal:  Blut       Date:  1979-10

Review 2.  [Humoral factors in the regulation of cell proliferation in haematopoiesis. I. Granulopoiesis and lymphopoiesis (author's transl)].

Authors:  E Heidemann
Journal:  Klin Wochenschr       Date:  1980-10-15

3.  Relationship between a spleen-derived immunosuppressive peptide 'SDIP' and the 'Facteur thymique sérique' (FTS): biochemical and biological comparison of the two factors.

Authors:  M Lenfant; L Millerioux; I Blazsek; N Duchange
Journal:  Immunology       Date:  1983-04       Impact factor: 7.397

4.  The effects of fractions (chalones) obtained from lymphoid organs on the immune response in vivo.

Authors:  J F Borel; C Feurer; P C Hiestand; H Stähelin
Journal:  Agents Actions       Date:  1978-10

5.  [Further purification of a tissue specific inhibitor in lymphopoiesis (lymphocyte chalone?) (author's transl)].

Authors:  E Heidemann; A Jung; J Masurczak; N Podgornik; H Schmidt; K Wilms
Journal:  Blut       Date:  1979-08

6.  Inhibition of the IgE-mediated activation of RBL-2H3 cells by TIPP, a novel thymic immunosuppressive pentapeptide.

Authors:  Qianqian Lian; Yanna Cheng; Chuanqing Zhong; Fengshan Wang
Journal:  Int J Mol Sci       Date:  2015-01-20       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.